Clinical trial
C-Reactive Protein (CRP) in Obese Diabetic Women
NCT00262548 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00262548 |
|---|---|
| Title | C-Reactive Protein (CRP) in Obese Diabetic Women |
| Official title | Interventions Study for the Control of Diabetes Mellitus Type 2 in Obese Women |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Mexican National Institute of Public Health |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Rosuvastatin, improvement of lipid profile |
| Enrollment | 100 |
| Start date | Oct 1, 2005 |
| First posted | Dec 7, 2005 |
| Last update posted | Aug 28, 2007 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: